The presence of red-cell hypochromia in thalassemia has led to the belief that the primary reason for this disorder is defective hemoglobin synthesis. Itano (1) first enunciated and Ingram and Stretton (2) elaborated on the proposition that in "beta" thalassemia there is a suppression of the production of the beta polypeptide chains that, with the alpha chains, make up normal adult hemoglobin (a482). This would lead to a diminished concentration in the blood of hemoglobin A, and allow for compensatory or relative increases of hemoglobins F (a2'y2) and A2 (a,82), neither containing beta chains. On the other hand, in "alpha" thalassemia it is proposed that the production of alpha chains is diminished, and since both hemoglobins F and A., in common with A, contain the alpha chain, one does not find compensatory or relative increases of F and A2' Hemoglobin H, the beta-chain tetramer, may be found in pedigrees of this type. The genetic evidence which has accumulated to date provides support for this theory (3) .
Studies of marrow morphology and of iron and porphyrin metabolism, in contrast to the concept of suppressed production of hemoglobin, suggest a severe dyspoiesis of hemoglobin syn-* Supported in part by the John A. Hartford Foundation, a grant from the Squibb Institute for Medical Research, and U. S. Public Health Service grants AM-00965 (C6, 7, 8) . A preliminary report of this work appeared in Nature (Lond.) 1962, 196, 781. tResearch Fellow, supported by U. S. Public Health Service fellowship (HPD-9250-C2) from the National Heart Institute. § Supported in part by U. S. Public Health Service research career program award (HE-K3-14,927) from the National Heart Institute. thesis in thalassemia. Large quantities of hemoglobin are apparently produced, but undergo premature destruction in the marrow (ineffective erythropoiesis) (4) (5) (6) (7) (8) (9) . Most of the hemoglobin released into the peripheral blood does not usually achieve a normal survival. Small differences in the relative turnover rates of the various circulating hemoglobins may be greatly magnified in the process of ineffective erythropoiesis.
This study deals chiefly with the cellular distribution of the hemoglobins and the relative rates at which they are synthesized and catabolized in the peripheral blood. The information derived assists in our understanding of thalassemia as a genetic defect of globin metabolism.
MATERIALS AND METHODS
The basic plan of this study was to follow the rate of appearance and disappearance of an isotopically labeled amino acid in the circulating pools of hemoglobins A, F, and A2 in three patients with thalassemia.
1. Patients. All three men showed the characteristic features of thalassemia and might be placed in an "intermediate" clinical category because of their relatively benign clinical courses; the patients were ambulatory during the studies. None had required transfusion in recent years. Each was physically active, but had mild anemia. Clinical data describing the patients are summarized in Table I . Although the state of homozygosity is difficult to define in thalassemia, the large quantities of fetal hemoglobin (from 22 to 94%v) and the family studies were consistent with homozygosity in the patients (see Appendix). Patient J.C. had moderate splenomegaly, whereas the other two patients had had splenectomy a number of years previously. The increased numbers of circulating normoblasts in these two patients probably occurred as a result of removal of the spleen. Red-cell morphology was characteristic of thalassemia in all patients because there was anisocytosis, poikilocytosis, hypochromia, target cells, and schistocytes. PATIENT Patient S.D. showed the most marked morphological alteration. Each patient received an iv injection of 200 yc of glycine-2-C'4 (SA, 40 ,uc per mg). 1 Blood samples were then taken daily for 10 days and then once or twice weekly for a total of 3 to 4 months, with heparin or acid citrate dextrose solution as the anticoagulant. Within 1 day of sample collection, the red cells were washed three times in 3 vol of saline, hemolyzed with 3 vol of water and 0.5 vol of toluene, shaken, and allowed to stand overnight at 40 C. The stroma was next separated in the Spinco model L ultracentrifuge at 138,000 X g for 1 hour. The clear hemoglobin solution was then placed in dialysis tubing and stored at 4°C in the phosphate-cyanide buffer used for chromatographic separation. The period between sampling and chromatographic separation did not exceed 2 weeks.
2. Hemoglobin separation. Column chromatography was carried out in two stages, as illustrated in Figure 1 . After preliminary fractionation of 750 to 1,000 mg of hemoglobin on Amberlite CG 50 with developer no. 2 of Allen, Schroeder, and Balog (10), fetal hemoglobin was further purified on carboxymethylcellulose by gradient elution according to the system of Huisman, Martis, and Dozy (11) . The method of separation was modified slightly in the case of patient C.G. because of the small amounts of hemoglobins A and A2 in his blood. (The 1 New England Nuclear Corporation, Boston, Mass.
Amberlite buffer pH was lowered from 7.18 to 7.10, and the phosphate molarity decreased from .044 to .042. The column temperature was increased with a heating tape from 40 C to 150 C to elute hemoglobin A and to 300 C to elute hemoglobin A2.) An automatic method of protein analysis was used to facilitate the separation of large numbers of samples. The separated dilute fractions were concentrated to small volumes by ultrafiltration through dialysis tubing. After dialysis against running tap water for 12 hours, they were Iyophilized and the protein was stored in tightly stoppered vials.
3. Determination of protein purita. One chromatographic separation was reserved for electrophoretic analysis of the separated concentrated fractions on starch gel and agar. Electrophoretic homogeneity was demonstrated for the A and F fractions of patients J.C. and S.D. There was some contamination of the A2 fractions with approximately 20%c A and a trace of F. The ratio obtained by dividing the spectrophotometric reading found at 280 mA by that at 540 m;u was used to identify the fraction rich in nonheme proteins. In the case of patient C.G., all of the A and A2 fractions of the study were electrophoretically analyzed on agar and starch gel, respectively. These fractions showed only the slightest traces of hemoglobin A and A2 of patient C.G. were present in such small a liquid scintillation counter (12, 13) . The counting amounts that before dialysis and lyophilization, meas-error (ratio of 2 SD of the count rate to the net count ured amounts of carrier hemoglobin were added to meas-rate) was no greater than 3%. ured amounts of the samples. The hemoglobin concen-6. Preparation of reticulocyte-rich and -poor cells.
trations were measured in the Beckman DU spectro-The preparation of reticulocyte-rich and -poor cell popuphotometer as cyanmethemoglobin at 540 mA or 420 mg. lations was accomplished by cold ultracentrifugation of SA was then multiplied by the appropriate correction 15 ml of blood in celluloid tubes at 11,000 X g for 1 hour.
factor.
The top millimeter of cells was used as the reticulo-5. Radioactivity analysis. Weighed amounts of the cyte-rich preparation, whereas the bottom 3 mm was lyophilized samples were completely burned in oxygen-taken as the reticulocyte-poor layer. The (14) as well as on the whole blood.
RESULTS
In each of the three patients with thalassemia, the rate of movement of the labeled glycine was more rapid through the circulating pools of hemoglobins A and A2 than it was through that of hemoglobin F (Figures 2-6 (17) .
Previous investigators have described the contour of the curve of appearance and disappearance of labeled glycine through the circulating red cells of normal and abnormal subjects (18, 19) . The normal curve achieves a maximum at 20 to 30 days, then maintains a plateau until red-cell death from senescence begins. At this point (approximately 100 days), the decline of the curve begins. The maximal decrement of the down slope usually occurs at 120 days, the normal mean life span of the red cell. In contrast, when red-cell death is due to random events, a decline in SA begins soon after the attainment of peak activity. In the analyses that follow, we shall speak of "random" and "senescent" death in this sense.
A description of the A and F curves of patient J.C. was provided in a preliminary report (20) . His hemoglobin F curve (Figure 2 ) describes a normal appearance of senescent death, except that the mean life span is shortened to 104 days, as estimated by the method of Neuberger and Niven (21) . In contrast, the gradual negative slopes of the A and A2 curves begin immediately after the peaks, indicating a low order of random destruction, with mean life spans of approximately 74 days. The turnover rates in the circulation 1682 Figure 4 , the points for hemoglobin A and A2 are plotted on a semilogarithmic scale beginning with the maximal values. The points fit a two-component exponential system, one component with a half life of about 1 day, containing approximately 30%7 of the total circulating pool of A, and the other with a half life of 29 days, containing the remaining 70%. The points for hemoglobin F are replotted on linear scale from the peak onward in Figure 5 . The complicated curve is analyzed as the summation of two curves, one representing a senescent population with a mean life span of 75 days, and the other, whose points well fit an exponential function, representing a population undergoing random destruction with a half life of 9 days. Each population contains 50% of the total F pool. From this model, turnover rates for "fast" and "slow" pools for each of the individual hemoglobins may be computed. The absolute turnover rates of each of these pools are shown in Table II , which demonstrates several important points. The total hemoglobin production of 55 g per day represents an expansion of hemoglobin synthesis to approximately 8 times the resting, normal condition and illustrates that this patient not only has an excellent erythroid marrow reserve, but also that the reserve remains in full use. Of the total hemoglobin production, approximately 80%o is expended in the synthesis of a pool of hemoglobin A with a half life of 1 day. Thus the patient evinces a markedly increased turnover of circulating hemoglobin. This process involves hemoglobin A to a disproportionate degree. What significance may be assigned to the previous splenectomy is not apparent, since patient C.G. also underwent splenectomy and showed dissimilar curves. It is important to note that Heinz body inclusions were prominent in the red cells of S.D. and of C.G., in the latter to a lesser degree. These inclusions have been described in splenectomized patients with beta thalassemia by Fessas (22) .
Their contribution, if any, to the bizarre hemoglobin SA curves awaits further investigation.
Patient C.G. (Figure 6 ) was particularly interesting because of his extraordinarily high concentration of fetal hemoglobin (94%o). We wondered whether such elevated levels of hemoglobin F occurred as a result of extraordinarily rapid turnover rates of hemoglobin A. Our study of this patient answered the question in the negative. Although we found the same qualitative pattern as in the other patients, the mean life span of the hemoglobins A and A2 was approximately 60 days, as compared to 95 days for fetal hemoglobin; this result compares with that for J.C., who had only 40%o F.
The.proper interpretation of these hemoglobin life-span curves depends, among other things, upon the assumption that the difference found between hemoglobins A and F is not due just to the removal from hemoglobin A of the minor component designated by Kunkel and Bearn as hemoglobin A3 (23) . This component has been described by them and by Ranney and Kono (17) as maintaining a lower SA than hemoglobin A early in the course of a red-cell life span, whereas later, as the cells age, the SA of A1 actually rises above that of the main component. Therefore it has been thought that A3, in spite of its altered electrophoretic and chromatographic properties, does not emerge from the ribosomes as such, but rather arises from some modification during ageing of hemoglobin A. The data of Table III confirm this peculiar isotopic pattern of hemoglobin A3. One may calculate, however, that the SA difference between A3 and A is not sufficient to account for the difference found between A and F, based on the evidence that A3 constitutes from only 4 to 12%c of the total A (10, 23). It is clear from our chromatographic separations that the proportion of A3 is not significantly increased in thalassemia.
If fetal hemoglobin improves the survival of red cells in thalassemia, old red cells should show a higher proportion of fetal hemoglobin than young. Old and young red cells from the three patients discussed above and from two other pa- tients were separated by centrifugation, and the fetal hemoglobin content of the various layers was determined. The results (Table IV) show clearly and consistently that in thalassemia old cells do, in fact, have a higher fetal hemoglobin concentration than young ones, thereby confirming the isotopic data. Although density, upon which the centrifugal separation depends, is not strictly a function of cellular age, the number of reticulocytes in the top layers seem great enough to dispel doubt that these were layers of young cells.
The staining technique for fetal hemoglobin of Betke and Kleihauer (24) was performed on blood films of the patients and also indicated, as most other investigators have thought (25) (26) (27) , that the distribution of fetal hemoglobin among the red cells was unequal. The heterogeneous hemoglobin content of the red cells in thalassemia, however, makes the interpretation difficult.
In Figure 7 , SA curves for the first 10 days of each study are shown on an enlarged scale. Although hemoglobins A and AN follow similar patterns, consistent differences can be observed. A. seems to achieve a slightly higher peak SA than A. The significance, if any, of this finding in thalassemia patients is unknown, since similar studies have not yet been performed in normal subjects.
DISCUSSION
The simultaneous occurrence of hemoglobins A, A9, and F in thalassemia presents an opportunity to make significant comparisons of hemoglobin turnover because so many of the variables that may complicate studies based on isotopic techniques may be common to all the hemoglobins. The data of Breathnach indicate that fetal and adult hemoglobin are synthesized side by side in the bone marrow (28) , and there seems to be no special predilection for one or the other to be made in extramedullary sites (29) . We can therefore safely assume that the cells making these hemoglobins are all bathed in the same extracellular pool of glycine. Beyond this point, we are forced to assume that there are no special differences of membrane transport or of intracellular amino-acid pool sizes among the erythroid series that are not direct reflections of synthetic activity. Available data indicate that there is no difference in glycine content of the three hemoglobins (30, 31) . Fetal hemoglobin, however, has 12 more serine residues than hemoglobins A and A2, and this difference could possibly influence the fetal curves through conversion of glycine to serine in vivo (32) .
The results of this investigation clearly indicate that the turnover rate of hemoglobin F is slower than that of hemoglobin A in thalassemia. In patients heterozygous for hereditary persistence of fetal hemoglobin, the cellular distribution of fetal hemoglobin appears to be homogeneous (26) . That these patients achieve hemoglobin F concentrations of only 12 to 38c has been used as an argument for the lower postnatal synthetic rate of hemoglobin F as compared to hemoglobin A (33) . The nature of the life spans of the individual hemoglobins in this condition has not yet been described.
In no conditions other than thalassemia and homozygous persistence of fetal hemoglobin does hemoglobin F appear in concentrations of over 50% after infancy (34 
